dr. william oh describes updated findings from the cou-aa-302 trial
Published 11 years ago • 48 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
0:49
dr. william oh discusses the cou-aa-302 trial
-
2:08
dr. howard scher on findings from the cou-aa-302 trial
-
11:46
review of the latest abstracts from the cou-aa-302 trial
-
1:34
william oh, md: comparison of chemotherapy to a secondary hormone at the time of progression
-
3:00
dr. william oh on corticosteroid use in the affirm study
-
2:35
dr. william oh on sequencing new treatments for prostate cancer
-
1:26
william oh, md: the efficacy of abiraterone plus prednisone in an elderly patient population
-
1:16
dr. charles ryan on the cou-aa-302 abiraterone acetate interim analysis results
-
8:13
v04-01: artificial intelligence (ai) generated patient information videos (pivs)
-
18:11
dr. eugene fine - consequences of ketogenic diets in cancer – from recharge to biomarkers
-
6:15
review of ovarian tumor types
-
1:34
dr. william oh on treatment choices for prostate cancer
-
2:00
william oh, md: differences between side effects of ar-targeted therapies
-
1:22
dr. william oh discusses dasatinib in metastatic castration-resistant prostate cancer
-
3:13
william oh, md – medical oncologist: advanced prostate cancer & making the most of doc appointments
-
1:29
dr. william oh on the role of corticosteroids in treatment sequencing
-
1:37
dr. oh discusses the use of abiraterone and docetaxel in prostate cancer
-
0:59
dr. william oh on risk factors for prostate cancer
-
1:17
dr. oh on a biomarker development trial in mcrpc
-
13:54
quality ablation - reproducible and standardized liver tumour treatment with cas-one® ir (english)
-
1:33
dr. oh discusses the utility of cabazitaxel
-
1:13
dr. william oh on combination therapy studies in prostate cancer